Compound · Dual GIP/GLP-1 agonist

Tirzepatide

Tirzepatida

FormatSignalis Bio lyophilized vial with 10 mg declared content, made in the United States and designated research grade.

Tirzepatide · Signalis Bio

What science explores · not a promise

  • Incretin signaling
  • Glucose response
  • Body composition

What it is

Tirzepatide is a synthetic peptide of thirty-nine amino acids that acts as a dual GIP/GLP-1 agonist. Its design builds on the GIP sequence and includes amino acid changes and a lipid modification. These features are part of its molecular identity and do not describe an indication for the catalog material. Research examines how two receptor systems participate in signals related to glucose, satiety, and adipose tissue. The scientific interest lies in distinguishing shared and individual responses of both pathways within defined metabolic models. Molecular structure and regulatory status are separate questions. Prescription tirzepatide-based medicines exist in some countries, but this research material is not one of those medicines.

This material is research grade and is not a medicine. Published observations depend on the experimental system and its controls; they are not a promise for people. Documentation of identity, purity, and origin must be evaluated independently of any scientific hypothesis or proposed biological mechanism.

Origin

This synthetic peptide is inspired by GIP, a natural intestinal hormone. It was described in metabolic research publications from industrial laboratories in the late 2010s. Its development combined peptide chemistry and receptor evaluation. A conceptual origin in natural signaling does not make the catalog material an extracted hormone or a medicine.

How it is studied

It is studied in cellular receptor assays, animal models, and human studies of tirzepatide-based medicines. Measurements include intracellular signals, glucose-dependent insulin secretion, metabolic markers, and body composition. Evidence from regulated pharmaceutical products must be separated from the characteristics documented for an individual research batch, including its identity and analytical quality. These studies make no promises of personal effects. Available human information has limitations and does not amount to evidence for this commercial batch. Interpretation requires reviewing controls, reproducibility, analytical identity, and differences between models before drawing scientific conclusions about the observations.

Related lessons

Dr. Peptide is a virtual presenter created with artificial intelligence; she is not a healthcare professional. This content is educational and is not medical advice, diagnosis or treatment. Decisions about your health belong with a licensed professional. Research-grade products; sale to adults 18+ only.

Follow us on Instagram · @Signalisbio